CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

Tuesday, March 14, 2017 1 min read

Key Takeaway: CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

Full Press Release Details

CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte.